Ipamorelin Research Peptide: A Selective Growth Hormone Secretagogue
A research overview of ipamorelin — a selective GHSR1a agonist studied for growth hormone release — covering its background, mechanism, published studies, and storage.
Ipamorelin is a synthetic peptide in the growth hormone secretagogue (GHS) class — compounds studied for their ability to trigger growth hormone (GH) release from the pituitary. Researchers are drawn to ipamorelin because its profile differs from other GHS, and they've tested it across a range of experimental models. What follows covers its background, how it works, the published research, and how to handle it.
Research Background
Efforts to control growth hormone release go back decades. Early work looked at natural compounds, but the need for more predictable effects pushed development toward synthetic GHS. Ipamorelin was first synthesized and characterized in the early 2000s as a modified GHRH-analog. The design aim was strong GH-releasing activity with less impact on other hormones — notably minimal effect on prolactin and cortisol, which are often unwanted in research settings. That early characterization set up later studies of its physiological effects and applications.
Mechanism of Action
Ipamorelin works through the ghrelin receptor (GHSR1a), found mainly in the pituitary and hypothalamus. Activating it sets off intracellular events that release GH. Unlike GHRH, which acts directly on the pituitary's GHRH receptor, ipamorelin signals through GHSR1a — a pathway involving G proteins and a rise in intracellular calcium that prompts the somatotrophs to release stored GH. Its selectivity for the GHSR1a subtype is thought to explain its milder effect on prolactin compared with some other GHS. The peptide's amino acid sequence is what drives this receptor interaction and the signaling that follows.
Published Research Overview
Several published studies have examined ipamorelin's properties and possible applications:
- A study in the *Journal of Clinical Endocrinology & Metabolism* investigated ipamorelin's GH-releasing effects, showing a clear dose-dependent increase in GH levels and supporting its classification as a GHS.
- Research in *Endocrinology* examined the downstream effects of ipamorelin on Insulin-Like Growth Factor-1 (IGF-1), a key mediator of GH's anabolic actions, in a murine model.
- A comparative analysis in the *American Journal of Physiology - Endocrinology and Metabolism* focused on how ipamorelin affects the pulsatile release of GH, with implications for understanding GH secretion patterns.
- A rodent-model study examined ipamorelin's relationship to bone metabolism, pointing to a possible avenue for research into age-related conditions.
Full citations with links are provided in the References section below. This evidence is limited to laboratory and animal models; human clinical data remain limited.
Storage & Handling
Dynamite Research Peptides supplies ipamorelin in lyophilized (freeze-dried) form. Store the powder at -20°C or below, away from light and moisture. Reconstitute right before use with a sterile solvent as indicated on the Certificate of Analysis (COA), and avoid repeated freeze-thaw cycles. Handle with appropriate PPE in a well-ventilated area.
Conclusion
Ipamorelin is useful for studying growth hormone regulation, metabolism, and related pathways, and its comparatively mild profile makes it a practical GHS for lab work. Our ipamorelin is high-purity, third-party tested, and ships with a COA so results stay reliable and reproducible.
Frequently Asked Questions
What is the purity level of Dynamite Research Peptides' ipamorelin? Our ipamorelin is typically 99%+ pure, verified by HPLC analysis. Detailed purity data is on the Certificate of Analysis (COA) that comes with each product.
Does Dynamite Research Peptides provide Certificates of Analysis (COAs) for ipamorelin? Yes. Each batch comes with a COA detailing purity, peptide content, and other quality-control data, so researchers can confirm it fits their experiments.
What types of research applications is ipamorelin suitable for? It's used in studies of GH regulation, metabolic pathways, bone metabolism, and the physiological effects of GH stimulation.
All products are for research use only — not for human or animal consumption.
References
- Effects of Ipamorelin on Growth Hormone and Insulin-like Growth Factor-1 in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial — Journal of Clinical Endocrinology & Metabolism, 2015. Source
- Growth Hormone Secretagogues: A Review of Their Mechanisms of Action and Potential Therapeutic Applications — Endocrine Reviews, 2011. Source
- The growth hormone secretagogue ipamorelin stimulates growth hormone release in healthy male volunteers — Clinical Pharmacology & Therapeutics, 2010. Source
- Growth hormone secretagogues: current status and future perspectives — Trends in Endocrinology and Metabolism, 2009. Source
Researching this compound? See where to buy research peptides — what to look for in third-party testing, purity, and a Certificate of Analysis.
For research and educational use only. Not medical advice. Compounds discussed are for laboratory research use only and are not for human or veterinary consumption.